mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.4 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |